These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma. Zhuang L, Lai J, Chen K, Ding T, Yuan Y, Ma Y, Kang H, Lin Z, Fan N, Ma J, Zeng Q, Xu X, Wang Q, Chen B. Oncol Rep; 2019 Jan; 41(1):397-404. PubMed ID: 30320386 [Abstract] [Full Text] [Related]
7. Relevance of intraocular involvement in the management of primary central nervous system lymphomas. Ferreri AJ, Blay JY, Reni M, Pasini F, Gubkin A, Tirelli U, Calderoni A, Zucca E, Cortelazzo S, Chassagne C, Tinguely M, Borisch B, Berger F, Ponzoni M, Cavalli F, International Extranodal Lymphoma Study Group (IELSG). Ann Oncol; 2002 Apr; 13(4):531-8. PubMed ID: 12056702 [Abstract] [Full Text] [Related]
8. Primary central nervous system lymphoma. DeAngelis LM. Recent Results Cancer Res; 1994 Apr; 135():155-69. PubMed ID: 8047690 [No Abstract] [Full Text] [Related]
14. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes. Hoffman PM, McKelvie P, Hall AJ, Stawell RJ, Santamaria JD. Eye (Lond); 2003 May; 17(4):513-21. PubMed ID: 12802353 [Abstract] [Full Text] [Related]
15. Central nervous system manifestations of marginal zone B-cell lymphoma. Bayraktar S, Stefanovic A, Montague N, Davis J, Murray T, Lossos IS. Ann Hematol; 2010 Oct; 89(10):1003-9. PubMed ID: 20440502 [Abstract] [Full Text] [Related]
16. Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network. Langner-Lemercier S, Houillier C, Soussain C, Ghesquières H, Chinot O, Taillandier L, Soubeyran P, Lamy T, Morschhauser F, Benouaich-Amiel A, Ahle G, Moles-Moreau MP, Moluçon-Chabrot C, Bourquard P, Damaj G, Jardin F, Larrieu D, Gyan E, Gressin R, Jaccard A, Choquet S, Brion A, Casasnovas O, Colin P, Reman O, Tempescul A, Marolleau JP, Fabbro M, Naudet F, Hoang-Xuan K, Houot R. Neuro Oncol; 2016 Sep; 18(9):1297-303. PubMed ID: 26951382 [Abstract] [Full Text] [Related]
17. Primary central nervous system lymphoma involving the hypothalamic-pituitary axis: a case series and pooled analysis. Shin DW, Kim JH, Kim YH, Cho YH, Hong SH. J Neurooncol; 2020 Apr; 147(2):339-349. PubMed ID: 32221784 [Abstract] [Full Text] [Related]
18. Late relapse of primary central nervous system lymphoma. Yamanaka R, Morii K, Shinbo Y, Sano M, Homma J, Tsuchiya N, Yajima N, Tsukamoto Y, Ogura R, Natsumeda M, Aoki H, Akiyama K, Saitoh T, Tamura T, Hondoh H, Kawaguchi A, Takahashi H, Fujii Y. Leuk Lymphoma; 2017 Feb; 58(2):475-477. PubMed ID: 27397141 [No Abstract] [Full Text] [Related]
20. [Malignant non-Hodgkin lymphoma of the central nervous system with ocular site. Value of vitrectomy for diagnosis]. Maalouf T, Angioi-Duprez K, Guibaud I, Baty V, May T, Plenat F, Canton P, George JL. J Fr Ophtalmol; 1997 Jun; 20(9):693-6. PubMed ID: 9587581 [Abstract] [Full Text] [Related] Page: [Next] [New Search]